SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancerJens Neumann, Andreas Jung|BMC Cancer|2011Cited by 154
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer–subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306Sebastian Stintzing, Volker Heinemann, Elke Jäger et al.|Annals of Oncology|2012Cited by 110
Prognostic value of cetuximab‐related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: Results from a randomized trial of the GERMAN AIO CRC Study GroupSebastian Stintzing, Volker Heinemann, Christine Kapaun et al.|International Journal of Cancer|2012Cited by 81